Lipella Pharmaceuticals, Inc. (LIPO) Income Statement
Lipella Pharmaceuticals, Inc. Income Statement
Last quarter (Q3 2025), Lipella Pharmaceuticals, Inc.'s total revenue was $0.00. In Q3, Lipella Pharmaceuticals, Inc.'s net income was $-1.25M. See Lipella Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 24 | Dec 23 | Mar 23 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| $ 536.36K | $ 449.62K | $ 184.16K | $ 259.35K | $ 961.68K | |
| $ -3.08M | $ -2.59M | $ -2.36M | $ -1.20M | $ -14.28K | |
| $ 2.00M | $ 2.16M | $ 226.19K | $ 718.38K | $ 42.59K | |
| Depreciation and Amortization | $ 2.89K | $ 1.69K | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -5.01M | $ -4.61M | $ -2.59M | $ -1.86M | $ -53.69K | |
| $ -5.08M | $ -4.75M | $ -2.59M | $ -1.92M | $ -56.86K | |
| $ 64.28K | $ 126.99K | $ -7.98K | $ 50.35K | $ -4.79K | |
| $ -5.02M | $ -4.62M | $ -2.60M | $ -1.87M | $ -61.66K | |
| $ -5.02M | $ -4.62M | $ -2.60M | $ -1.87M | $ -61.66K | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.79 | $ -6.16 | $ -5.12 | $ -4.38 | $ -0.23 |
| Diluted EPS | $ -4.79 | $ -6.16 | $ -5.12 | $ -4.38 | $ -0.23 |
| Weighted Average Shares Outstanding | 1.05M | 749.83K | 507.36K | 426.01K | 266.40K |
| Weighted Average Shares Outstanding (Diluted) | 1.05M | 750.38K | 507.58K | 426.01K | 266.40K |
Currency in USD
